tiprankstipranks
Advertisement
Advertisement

Mach7 Resets Strategy as Profitability Slips on Lower Licence Sales

Story Highlights
  • Mach7’s first-half FY26 revenue fell on weaker capital licence sales, but recurring revenue rose to 85 percent of total and cost cuts improved operating efficiency.
  • Under new CEO Teri Thomas, Mach7 launched its Flamingo architecture, reshaped sales and operations, and is positioning to tap consolidation and growth in enterprise imaging markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mach7 Resets Strategy as Profitability Slips on Lower Licence Sales

Claim 55% Off TipRanks

Mach7 Technologies ( (AU:M7T) ) just unveiled an update.

Mach7 Technologies reported first-half FY26 revenue of A$13.7 million, down 23% year on year, as fewer one-off capital software licence deals and some customer churn weighed on results despite recurring revenue rising to 85% of total. Operating expenses fell 6% due to lower staff costs and efficiency gains, but adjusted EBITDA slipped to a loss of A$2.3 million, with NPAT also weakening, although the company maintained a solid balance sheet with A$18.5 million in cash and no debt.

New CEO Teri Thomas highlighted a strategic reset over her first six months, including the launch of the Flamingo architecture, the first contract for Flamingo in December 2025, and a rebuilt sales and marketing model to support sustainable, profitable growth. Management is emphasizing disciplined cost control while redirecting resources toward product innovation, a strengthened “Flight Crew” customer engagement model, and an expanded marketing push, positioning Mach7 to capitalise on provider consolidation and growing global adoption of enterprise imaging in the second half and beyond.

The most recent analyst rating on (AU:M7T) stock is a Hold with a A$0.34 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.

More about Mach7 Technologies

Mach7 Technologies is an ASX-listed healthcare software company that provides enterprise imaging solutions, enabling health systems to securely store, access and share diagnostic images across disparate systems. The company focuses on interoperable imaging platforms and viewers, including its eUnity Viewer and the new Flamingo architecture, targeting hospitals and large provider networks undergoing consolidation and digital transformation.

Average Trading Volume: 300,281

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$79.9M

For an in-depth examination of M7T stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1